Back to Journals » Journal of Pain Research » Volume 7

Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study

Total article views   HTML views PDF downloads Totals
18,336 Dovepress* 14,659+ 1,956 16,615
PubMed Central* 3,677 754 4,431
Totals 18,336 2,710 21,046
*Since 22 August 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 0 8

View citations on PubMed Central and Google Scholar